Get the Stockscreener App
0.8519
2.70%
0.0224
After Hours:
.83
-0.0219
-2.57%
Aptorum Group Ltd stock is traded at $0.8519, with a volume of 2,066.
It is up +2.70% in the last 24 hours and down -18.09% over the past month.
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.
See More
Previous Close:
$0.8295
Open:
$0.82
24h Volume:
2,066
Relative Volume:
0.03
Market Cap:
$6.94M
Revenue:
$431.40K
Net Income/Loss:
$-1.95M
P/E Ratio:
-2.4236
EPS:
-0.3515
Net Cash Flow:
$-726.80K
1W Performance:
+15.06%
1M Performance:
-18.09%
6M Performance:
-38.71%
1Y Performance:
-32.92%
1-Day Range:
$0.82
$0.86
1-Week Range:
$0.75
$0.8799
52-Week Range:
$0.6899
$4.47
Aptorum Group Ltd Stock (APM) Company Profile
Compare APM vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APM
Aptorum Group Ltd
|
0.8519 | 6.76M | 431.40K | -1.95M | -726.80K | -0.3515 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Aptorum Group Ltd Stock (APM) Latest News
Aptorum Group schedules 2025 annual general meeting for March in Hong Kong By Investing.com - Investing.com South Africa
Aptorum Group schedules 2025 annual general meeting for March in Hong Kong - Investing.com
Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB’s Automated APOE Testing Platform for Alzheimer’s Disease - The Manila Times
Will Aptorum Group Limited outperform small cap indexes2025 Risk Factors & Precise Buy Zone Identification - mfd.ru
Andean Precious Metals Announces C$83.1 Million Bought Public Secondary Offering of Common Shares - markets.businessinsider.com
Trend Recap: Can Aptorum Group Limited continue delivering strong returnsJuly 2025 Intraday Action & Expert Approved Momentum Ideas - baoquankhu1.vn
Aptorum Group (NASDAQ:APM) vs. BioNxt Solutions (OTCMKTS:BNXTF) Head-To-Head Review - Defense World
Can Aptorum Group Limited stock hit analyst price targetsJuly 2025 Update & Daily Chart Pattern Signal Reports - Улправда
Sentiment Review: Will Aptorum Group Limited stock benefit from upcoming earnings reportsJuly 2025 Pullbacks & Capital Efficiency Focused Ideas - Улправда
Aptorum Group Limited (NASDAQ:APM) Sees Significant Decline in Short Interest - Defense World
Aptorum Group (NASDAQ:APM) Stock Price Up 3.5% – Should You Buy? - Defense World
How interest rate cuts could boost Aptorum Group Limited stockQuarterly Trade Report & Community Verified Watchlist Alerts - Улправда
Can Aptorum Group Limited stock beat market expectations this quarter2025 Support & Resistance & Fast Entry High Yield Stock Tips - Улправда
Aptorum Group (APM) Stock Analysis Report | Financials & Insights - Benzinga
Aptorum Group Limited (APM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Aptorum Group Limited stock a buy before product launches - newser.com
The time has not yet come to remove your chips from the table: Aptorum Group Ltd (APM) - Setenews
DiamiR and Aptorum Group (NASDAQ: APM) to Present Alzheimer’s microRNA Data at CTAD 2025 - Stock Titan
Applying Wyckoff theory to Aptorum Group Limited stock2025 Trade Ideas & Fast Gain Swing Alerts - newser.com
Aptorum Group LimitedClass A Ordinary Shares (Nasdaq:APM) Stock Quote - FinancialContent
[F-1] Aptorum Group Ltd Foreign Issuer IPO Registration | APM SEC FilingForm F-1 - Stock Titan
How Aptorum Group Limited stock trades during market volatilityMarket Growth Review & Safe Swing Trade Setups - newser.com
How Aptorum Group Limited stock reacts to global recession fearsDay Trade & AI Enhanced Market Trend Forecasts - Fundação Cultural do Pará
Will Aptorum Group Limited stock sustain high P E ratios2025 Macro Impact & Technical Confirmation Alerts - newser.com
Advanced analytics toolkit walkthrough for Aptorum Group Limited2025 Market Outlook & Verified Short-Term Trading Plans - newser.com
Custom strategy builders for tracking Aptorum Group Limited2025 Volume Leaders & High Conviction Investment Ideas - newser.com
Why retail investors favor Aptorum Group Limited stockMarket Movers & AI Powered Trade Plan Recommendations - newser.com
Aptorum Group Limited stock trendline breakdownQuarterly Profit Review & Stock Portfolio Risk Control - newser.com
How Aptorum Group Limited stock compares to market leadersForecast Cut & Expert Curated Trade Ideas - newser.com
Has Aptorum Group Limited formed a bullish divergence2025 Support & Resistance & Free Technical Pattern Based Buy Signals - newser.com
Aptorum Group Limited (APM) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Can technical indicators confirm Aptorum Group Limited’s reversalJuly 2025 Setups & High Yield Equity Trading Tips - newser.com
Real time scanner hits for Aptorum Group Limited explainedRate Cut & Real-Time Volume Analysis Alerts - newser.com
How to monitor Aptorum Group Limited with trend dashboards2025 Biggest Moves & Free Safe Capital Growth Stock Tips - newser.com
How Aptorum Group Limited stock reacts to oil prices2025 Sector Review & Free Risk Controlled Daily Trade Plans - Fundação Cultural do Pará
Will Aptorum Group Limited stock gain from strong economy2025 Year in Review & Verified Stock Trade Ideas - newser.com
Measuring Aptorum Group Limited’s beta against major indicesJuly 2025 Catalysts & Low Risk Growth Stock Ideas - newser.com
What to expect from Aptorum Group Limited in the next 30 daysMarket Performance Recap & Reliable Breakout Forecasts - newser.com
Aptorum Group Ltd Stock (APM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):